| ONCY Stock | | | USD 0.94 0.01 1.05% |
Oncolytics Biotech financial indicator trend analysis is much more than just breaking down Oncolytics Biotech prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Oncolytics Biotech is a good investment. Please check the relationship between Oncolytics Biotech Accounts Payable and its Net Receivables accounts. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oncolytics Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in main economic indicators.
For more information on how to buy Oncolytics Stock please use our
How to Invest in Oncolytics Biotech guide.
Accounts Payable vs Net Receivables
Accounts Payable vs Net Receivables Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Oncolytics Biotech Accounts Payable account and
Net Receivables. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Oncolytics Biotech's Accounts Payable and Net Receivables is -0.05. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Net Receivables in the same time period over historical financial statements of Oncolytics Biotech, assuming nothing else is changed. The correlation between historical values of Oncolytics Biotech's Accounts Payable and Net Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Oncolytics Biotech are associated (or correlated) with its Net Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Receivables has no effect on the direction of Accounts Payable i.e., Oncolytics Biotech's Accounts Payable and Net Receivables go up and down completely randomly.
Correlation Coefficient | -0.05 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Accounts Payable
An accounting item on the balance sheet that represents Oncolytics Biotech obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Oncolytics Biotech are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Net Receivables
Most indicators from Oncolytics Biotech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Oncolytics Biotech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oncolytics Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in main economic indicators.
For more information on how to buy Oncolytics Stock please use our
How to Invest in Oncolytics Biotech guide.At this time, Oncolytics Biotech's
Selling General Administrative is fairly stable compared to the past year.
Enterprise Value is likely to rise to about 118
M in 2024, whereas
Tax Provision is likely to drop slightly above 84.1
K in 2024.
Oncolytics Biotech fundamental ratios Correlations
Click cells to compare fundamentals
Oncolytics Biotech Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Oncolytics Biotech fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Oncolytics Stock Analysis
When running Oncolytics Biotech's price analysis, check to
measure Oncolytics Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncolytics Biotech is operating at the current time. Most of Oncolytics Biotech's value examination focuses on studying past and present price action to
predict the probability of Oncolytics Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncolytics Biotech's price. Additionally, you may evaluate how the addition of Oncolytics Biotech to your portfolios can decrease your overall portfolio volatility.